Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

200979 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 4, Issue 1, pp. 87-92

Field-Weighted Citation Impact: 10.27